Estados financieros detallados de Pyxis Oncology, Inc. (PYXS): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 99.8%, margen operativo -8.3%, margen neto -8.0%.
Al precio actual de $3.34, PYXS presenta beneficios negativos (P/E no significativo) y un ROE del -215.23%. La capitalización bursátil es de $212M.
Cuenta de Resultados (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | $16.1M | $13.9M |
| Coste de Ventas | 0 | $444000 | 0 | 0 | 0 | $475000 | $2.4M |
| Beneficio Bruto | 0 | -$444000 | 0 | 0 | 0 | $15.7M | $11.5M |
| I+D | $1.2M | $8.6M | $51.1M | $86.1M | $49.6M | $58.7M | $73.7M |
| Generales y Administrativos | $1.7M | $3.8M | $18.7M | $37.4M | $32.6M | $25.4M | $22.2M |
| Gastos Operativos | $2.9M | $12.4M | $69.7M | $123.5M | $82.2M | $105.1M | $95.9M |
| Beneficio Operativo | -$2.9M | -$12.9M | -$69.7M | -$123.5M | -$82.2M | -$89.5M | -$84.4M |
| EBITDA | -$2.8M | -$12.4M | -$75.3M | -$120.0M | -$71.9M | -$65.5M | -$73.7M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$2.8M | -$12.8M | -$76.0M | -$120.7M | -$73.8M | -$79.5M | -$78.2M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | -$2.2M | $1.4M |
| Beneficio Neto | -$2.8M | -$12.8M | -$76.0M | -$120.7M | -$73.8M | -$77.3M | -$79.6M |
| BPA | $-0.08 | $-0.37 | $-2.53 | $-3.57 | $-1.85 | $-1.32 | $-1.28 |
| BPA Diluido | $-0.08 | $-0.37 | $-2.53 | $-3.57 | $-1.85 | $-1.32 | $-1.28 |
| Acciones en Circulación (Diluidas) | $34.3M | $34.3M | $32.2M | $33.0M | $39.9M | $58.4M | $62.1M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | $11.0M | 0 | 0 |
| Beneficio Bruto | 0 | $11.5M | -$459000 | 0 |
| Beneficio Operativo | -$23.5M | -$18.3M | -$24.4M | -$26.0M |
| EBITDA | -$21.5M | -$14.1M | -$22.8M | -$25.0M |
| Beneficio Neto | -$22.0M | -$18.1M | -$23.3M | -$25.3M |
| BPA | $-0.35 | $-0.29 | $-0.37 | $-0.40 |
| BPA Diluido | $-0.35 | $-0.29 | $-0.37 | $-0.40 |
Balance (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $19.7M | $8.1M | $274.7M | $179.3M | $9.7M | $19.5M | $15.4M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | $109.6M | $107.5M | $51.4M |
| Cuentas por Cobrar | 0 | 0 | 0 | $598000 | $21000 | 0 | $700000 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $19.7M | $8.1M | $278.7M | $186.6M | $124.6M | $132.4M | $72.1M |
| Inmovilizado Material | $76000 | $1.9M | $1.2M | $24.8M | $24.8M | $22.1M | $19.4M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | $24.3M | $2.6M | 0 |
| Activos Totales | $19.8M | $10.2M | $280.0M | $211.4M | $173.7M | $157.2M | $91.5M |
| Cuentas por Pagar | $491000 | $1.1M | $12.0M | $7.1M | $3.9M | $4.9M | $10.9M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $733000 | $3.7M | $18.7M | $31.6M | $25.8M | $17.7M | $21.1M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $22.7M | $25.8M | $18.7M | $50.6M | $48.0M | $36.4M | $38.1M |
| Reservas | -$2.9M | -$15.7M | -$91.7M | -$212.4M | -$286.2M | -$363.6M | -$443.2M |
| Patrimonio Neto | -$2.9M | -$15.6M | $261.3M | $160.8M | $125.7M | $120.8M | $53.4M |
| Deuda Total | $15000 | $780000 | $165000 | $18.9M | $21.3M | $20.2M | $18.7M |
| Deuda Neta | -$19.7M | -$7.3M | -$274.6M | -$160.4M | -$98.0M | -$106.7M | -$48.2M |
| Capital Circulante | $19.0M | $4.4M | $260.0M | $155.0M | $98.8M | $114.8M | $51.0M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $8.9M | $15.4M | $7.2M | $18.9M |
| Activos Totales | $105.6M | $91.5M | $64.3M | $54.9M |
| Pasivos Totales | $36.8M | $38.1M | $33.0M | $43.5M |
| Patrimonio Neto | $68.8M | $53.4M | $31.3M | $11.4M |
| Deuda Total | $19.1M | $18.7M | $18.3M | $17.8M |
Flujo de Caja (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$2.8M | -$12.8M | -$76.0M | -$120.7M | -$73.8M | -$77.3M | -$79.6M |
| Amortizaciones | 0 | $469000 | $647000 | $709000 | $1.9M | $3.0M | $4.5M |
| Compensación en Acciones | $28000 | $44000 | $6.4M | $15.8M | $16.9M | $12.9M | $11.8M |
| Cambio en Capital Circulante | $505000 | $2.3M | $6.7M | $4.5M | -$11.7M | -$11.8M | $1.9M |
| Flujo de Caja Operativo | -$2.2M | -$10.1M | -$35.3M | -$89.3M | -$70.7M | -$57.7M | -$63.5M |
| Inversiones (CapEx) | 0 | -$1.5M | -$540000 | -$6.4M | -$6.7M | -$237000 | -$9000 |
| Adquisiciones | 0 | 0 | -$50000 | 0 | $6.7M | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$2.2M | -$11.6M | -$35.9M | -$95.7M | -$77.4M | -$57.9M | -$63.5M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$13.3M | -$10.4M | -$26.0M | -$18.2M |
| Inversiones (CapEx) | -$9000 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$13.3M | -$10.4M | -$26.0M | -$18.2M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $3.1M | $2.1M | $1.2M | $5.5M |
Crecimiento y Márgenes (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | | | | | | -14.2% |
| Crecimiento Beneficio Neto (anual) | | -362.8% | -492.3% | -58.9% | +38.9% | -4.8% | -3.0% |
| Crecimiento BPA (anual) | | -376.2% | -583.8% | -41.1% | +48.2% | +28.6% | +3.0% |
| Cambio en Acciones (anual) | | +0.0% | -6.1% | +2.5% | +20.8% | +46.5% | +6.3% |
| Crecimiento FCF (anual) | | -416.6% | -210.1% | -166.9% | +19.1% | +25.2% | -9.7% |
| Margen Bruto | | | | | | 97.1% | 82.8% |
| Margen Operativo | | | | | | -554.1% | -609.2% |
| Margen EBITDA | | | | | | -405.8% | -532.0% |
| Margen Neto | | | | | | -478.9% | -574.5% |
| Margen FCF | | | | | | -358.7% | -458.3% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | 2.7% | -1.8% |
Datos por Acción (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-0.07 | $-0.34 | $-1.11 | $-2.90 | $-1.94 | $-0.99 | $-1.02 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $34.3M | $34.3M | $32.2M | $33.0M | $39.9M | $58.4M | $62.1M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -215.23% |
| Rentabilidad sobre capital invertido | -314.66% |
| Rentabilidad sobre activos | -161.55% |
| Margen bruto | 99.76% |
| Margen operativo | -834.44% |
| Margen neto | -803.83% |
Salud financiera
| Deuda / Patrimonio | 1.56 |
| Ratio corriente | 1.34 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -7.88 |
Ratios Clave (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -169.88 | -35.68 | -4.34 | -0.38 | -0.97 | -1.18 | -0.90 |
| P/VC | -157.58 | -28.95 | 1.35 | 0.28 | 0.57 | 0.76 | 1.34 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.65 | 5.16 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 97.1% | 82.8% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -554.1% | -609.2% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -478.9% | -574.5% |